rs772746106
Variant summary
Our verdict is Uncertain significance. Variant got -1 ACMG points: 0P and 1B. BP4
This summary comes from the ClinGen Evidence Repository: The c.2957G>A (NM_006939.4(SOS2):c.2957G>A (p.Arg986Lys)) variant in SOS2 is a missense variant predicted to cause substitution of arginine by lysine at amino acid 986. The highest MAF in gnomAD v2.1.1 is 0.004629 % in the African/African American population (no population codes met). The computational predictor REVEL gives a score of 0.051, which is below the threshold of 0.3, evidence that does not predict a damaging effect on SOS2 function (BP4). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal dominant RASopathy, based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: BP4 (Version 2.3; 12/3/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA7176917/MONDO:0021060/042
Frequency
Consequence
NM_006939.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOS2 | ENST00000216373.10 | c.2957G>A | p.Arg986Lys | missense_variant, splice_region_variant | Exon 18 of 23 | 1 | NM_006939.4 | ENSP00000216373.5 | ||
SOS2 | ENST00000543680.5 | c.2858G>A | p.Arg953Lys | missense_variant, splice_region_variant | Exon 17 of 22 | 1 | ENSP00000445328.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151672Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000157 AC: 3AN: 190868Hom.: 0 AF XY: 0.0000191 AC XY: 2AN XY: 104760
GnomAD4 exome AF: 0.0000403 AC: 54AN: 1340620Hom.: 0 Cov.: 23 AF XY: 0.0000315 AC XY: 21AN XY: 667300
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151672Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74002
ClinVar
Submissions by phenotype
Noonan syndrome 9 Uncertain:2
- -
This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 986 of the SOS2 protein (p.Arg986Lys). This variant is present in population databases (rs772746106, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with SOS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 475749). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.R986K variant (also known as c.2957G>A), located in coding exon 18 of the SOS2 gene, results from a G to A substitution at nucleotide position 2957. The arginine at codon 986 is replaced by lysine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
RASopathy Uncertain:1
The c.2957G>A (NM_006939.4(SOS2):c.2957G>A (p.Arg986Lys)) variant in SOS2 is a missense variant predicted to cause substitution of arginine by lysine at amino acid 986. The highest MAF in gnomAD v2.1.1 is 0.004629 % in the African/African American population (no population codes met). The computational predictor REVEL gives a score of 0.051, which is below the threshold of 0.3, evidence that does not predict a damaging effect on SOS2 function (BP4). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal dominant RASopathy, based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: BP4 (Version 2.3; 12/3/2024). -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at